Can weed cause hair loss? It is a question asked with increasing frequency as cannabis use grows more common across the UK. Currently, there is no definitive clinical evidence establishing a direct causal link between cannabis use and hair loss. Whilst some theoretical biological mechanisms have been proposed — involving the endocannabinoid system and hormonal pathways — these remain speculative. This article examines what the science actually says, explores other well-established causes of hair loss, and outlines when to seek medical advice and what treatment options are available through the NHS.
Summary: Can weed cause hair loss? There is currently no definitive clinical evidence that cannabis directly causes hair loss, though theoretical biological mechanisms involving the endocannabinoid system have been proposed.
- No large-scale, peer-reviewed studies have conclusively established a causal link between cannabis use and alopecia or accelerated hair shedding.
- THC and CBD interact with CB1 and CB2 receptors found in hair follicles, but experimental findings from isolated tissue models have not been confirmed as clinically significant in humans.
- UK-licensed cannabis-based medicinal products, including Sativex and Epidyolex, do not list alopecia as a recognised adverse effect in their Summaries of Product Characteristics.
- Hair loss is multifactorial; androgenetic alopecia, telogen effluvium, nutritional deficiencies, and thyroid disorders are far more commonly and conclusively linked causes.
- Individuals who use cannabis may also smoke tobacco, experience poor nutrition, or have elevated psychological stress — all independent, well-established contributors to hair loss.
- Suspected medication or substance side effects, including those related to cannabis, can be reported to the MHRA via the Yellow Card scheme.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
What the Evidence Says About Cannabis and Hair Loss
There is no definitive clinical evidence that cannabis directly causes hair loss; UK-licensed cannabis-based medicines do not list alopecia as a recognised adverse effect, and existing concerns are largely based on anecdotal reports and uncontrolled observations.
Experiencing these side effects? Our pharmacists can help you navigate them →
The question of whether cannabis (commonly referred to as 'weed') can cause hair loss has gained increasing attention as its use becomes more widespread. It is important to state clearly that there is currently no definitive clinical evidence establishing a direct causal link between cannabis use and hair loss. No large-scale, peer-reviewed studies have conclusively demonstrated that smoking or consuming cannabis directly triggers alopecia or accelerated hair shedding in otherwise healthy individuals.
It is also worth distinguishing between recreational cannabis and UK-licensed cannabis-based medicinal products (CBMPs). The Summaries of Product Characteristics (SmPCs) for UK-licensed CBMPs — including nabiximols (Sativex) and cannabidiol (Epidyolex) — do not list alopecia as a recognised adverse effect. This does not, however, prove that recreational cannabis has no effect on hair; it simply means that alopecia has not been identified as an adverse effect in the clinical trial populations studied for these licensed medicines.
The absence of strong evidence does not mean the relationship is entirely without basis. Some researchers have proposed theoretical mechanisms through which cannabis could potentially influence hair biology, largely related to the endocannabinoid system and hormonal pathways. These remain speculative and are discussed further below.
Much of the concern in the public domain stems from anecdotal reports and small observational studies, which are insufficient to draw firm conclusions. Additionally, many individuals who use cannabis also engage in other behaviours — such as poor nutrition, high psychological stress, tobacco smoking, or use of other substances — that are themselves well-established contributors to hair loss. Separating any specific effect of cannabis from these confounding factors remains a significant methodological challenge. Until more robust research is available, any claims linking cannabis directly to hair loss should be interpreted with caution.
Not sure if this is normal? Chat with one of our pharmacists →
If you suspect a medicine or substance is causing a side effect, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.
| Potential Factor | Proposed Mechanism | Strength of Evidence | Clinical Significance |
|---|---|---|---|
| THC (CB1 receptor activation) | May promote premature catagen entry, inhibiting hair shaft elongation | Ex vivo / experimental models only | Not confirmed as clinically significant in humans |
| THC and DHT elevation | Possible influence on HPG axis, potentially raising DHT levels | Inconsistent; not supported by robust human clinical data | Uncertain; relevance to androgenetic alopecia unproven |
| Cannabis and cortisol changes | Chronic cortisol elevation may trigger telogen effluvium | Inconsistent findings across literature | Sustained cortisol effect sufficient to affect hair not established |
| Tobacco co-use | Smoking independently associated with hair loss and follicle damage | Well-established confounding factor | Difficult to separate from any cannabis-specific effect |
| Poor nutrition / appetite disruption | Iron, ferritin, vitamin D, and protein deficiencies trigger telogen effluvium | Well-established independent cause | Common confounder in cannabis users; warrants investigation |
| Psychological stress | Stress-induced cortisol elevation disrupts hair cycle | Well-established independent cause | Recognised trigger for telogen effluvium; assess separately |
| UK-licensed CBMPs (e.g., Sativex, Epidyolex) | N/A — alopecia not listed as adverse effect in SmPC | No signal from clinical trial populations | Does not confirm recreational cannabis is safe for hair |
How Cannabis May Affect Hair Growth Cycles
CB1 receptor activation may theoretically promote premature entry into the catagen (shedding) phase of the hair cycle, but this evidence comes from experimental tissue models and has not been confirmed as clinically significant in humans.
To understand how cannabis might theoretically influence hair, it helps to consider the biology of hair growth. Hair follicles cycle through distinct phases: anagen (active growth), catagen (transition), and telogen (resting/shedding). Disruptions to this cycle — from hormonal changes, nutritional deficiencies, or physiological stress — can result in increased shedding, a condition known as telogen effluvium.
Cannabis contains over 100 cannabinoids, the most studied being delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). These compounds interact with the body's endocannabinoid system (ECS), which includes CB1 and CB2 receptors found throughout the body — including in hair follicles. Importantly, THC acts primarily as a CB1 agonist, whilst CBD has more complex, modulatory effects; their biological actions are not equivalent and should not be treated as uniform. Laboratory and ex vivo research (i.e., studies conducted on isolated tissue rather than in living humans) suggests that CB1 receptor activation may act as a negative regulator of hair shaft elongation and could promote premature entry into the catagen phase. However, this evidence comes from experimental models and does not establish clinical causation in humans.
Some studies have suggested that cannabinoids may influence the hypothalamic–pituitary–gonadal (HPG) axis, potentially affecting sex hormone levels. However, the specific claim that THC reliably increases dihydrotestosterone (DHT) — a hormone strongly associated with androgenetic alopecia — is not consistently supported by human clinical data, and its significance in practice remains uncertain. Any such hormonal effect is likely to vary considerably depending on dose, frequency of use, route of administration, and individual biology.
Cannabis use has also been associated with changes in cortisol levels in some studies, though findings are inconsistent across the literature. Chronic elevation of cortisol is a recognised trigger for telogen effluvium, but whether cannabis use produces sustained cortisol changes sufficient to affect hair growth in humans has not been established.
In summary, whilst there are plausible biological mechanisms by which cannabis could theoretically influence hair follicle cycling, none of these pathways has been confirmed as clinically significant in humans. More robust human clinical trials are needed before any firm conclusions can be drawn.
Other Factors That Can Contribute to Hair Loss
Androgenetic alopecia, telogen effluvium, nutritional deficiencies, thyroid disorders, and autoimmune conditions are well-established and far more common causes of hair loss than cannabis use.
When evaluating hair loss in someone who uses cannabis, it is essential to consider the full clinical picture. Hair loss is a multifactorial condition, and numerous other causes are far more commonly — and more conclusively — linked to hair shedding and thinning. Attributing hair loss to a single cause without proper investigation can delay appropriate treatment.
Common and well-established causes of hair loss include:
-
Androgenetic alopecia — the most prevalent form, affecting both men and women, driven by genetic predisposition and DHT sensitivity
-
Telogen effluvium — diffuse shedding triggered by physical or emotional stress, illness, surgery, significant weight loss, or nutritional deficiency
-
Nutritional deficiencies — particularly iron deficiency anaemia, low ferritin, vitamin D deficiency, and inadequate protein intake
-
Thyroid disorders — both hypothyroidism and hyperthyroidism can cause significant hair thinning
-
Autoimmune conditions — such as alopecia areata, where the immune system attacks hair follicles
-
Hormonal changes — including those related to pregnancy, the postpartum period, menopause, or polycystic ovary syndrome (PCOS)
-
Traction alopecia — hair loss caused by prolonged tension on the hair from tight hairstyles
-
Tinea capitis — a fungal scalp infection that can cause patchy hair loss, particularly in children, and requires prompt treatment
-
Trichotillomania — a compulsive urge to pull out one's own hair, which may benefit from psychological support
-
Scarring (cicatricial) alopecias — such as lichen planopilaris or frontal fibrosing alopecia, which cause permanent follicle destruction if untreated; these require urgent specialist assessment
-
Medications — certain drugs, including anticoagulants, retinoids, and some antidepressants, list hair loss as a recognised side effect
Lifestyle factors also play a role. Poor diet, excessive alcohol consumption, tobacco smoking, disrupted sleep, and chronic psychological stress are all independently associated with hair loss. Individuals who use cannabis recreationally may also smoke tobacco or experience appetite and sleep disruption — factors that could plausibly affect hair health as confounders, though direct causation should not be assumed.
A thorough medical history and appropriate investigations are essential before attributing hair loss to cannabis use specifically. The NHS hair loss overview and Primary Care Dermatology Society (PCDS) guidance provide useful frameworks for understanding the range of causes.
When to Seek Medical Advice About Hair Loss
See your GP promptly if you experience sudden, patchy, or rapidly worsening hair loss, especially if accompanied by scalp inflammation, systemic symptoms, or significant distress, as early assessment can prevent irreversible damage.
Hair loss can be distressing, and whilst some degree of daily shedding (typically 50–100 hairs per day) is entirely normal, certain patterns and symptoms warrant prompt medical attention.
Contact your GP if you notice:
-
Sudden or rapid hair loss over a short period
-
Patchy hair loss or bald spots on the scalp or elsewhere on the body
-
Hair loss accompanied by scalp redness, itching, scaling, pain, or pustules
-
Broken hairs with scalp scaling or associated lymph node swelling — which may suggest tinea capitis, particularly in children
-
Progressive or worsening thinning
-
Hair loss alongside other symptoms such as fatigue, unexplained weight changes, or irregular periods — which may suggest an underlying systemic condition
-
Significant psychological distress related to hair loss
Seek urgent GP assessment if you suspect scarring alopecia (e.g., a receding hairline with scalp inflammation, or areas of permanent-looking hair loss with follicular destruction), as early treatment is important to prevent irreversible damage.
Your GP will typically begin with a detailed medical and medication history, followed by a physical examination of the scalp and hair pattern. In UK primary care, first-line blood tests commonly include:
-
Full blood count (to check for anaemia)
-
Serum ferritin (iron stores)
-
Thyroid function tests (TSH)
Additional investigations — such as vitamin D, vitamin B12, or hormonal profiles — are generally reserved for people with clinical features suggesting deficiency or hormonal imbalance (for example, signs of hyperandrogenism or malabsorption), in line with NICE CKS guidance.
If you use cannabis and are concerned it may be contributing to your hair loss, it is advisable to discuss this openly with your GP. They can help assess whether cannabis use may be a contributing factor in the context of your overall health, without judgement.
For persistent or diagnostically uncertain hair loss, your GP can refer you to NHS dermatology services for specialist assessment. If you choose to consult a trichologist independently, please be aware that trichologists are not medical doctors, are not regulated by the General Medical Council, and are not part of the standard NHS referral pathway; any concerns about underlying medical causes should always be assessed by a qualified clinician.
Treatments and Support Options for Hair Loss in the UK
Treatment depends on the underlying cause; options include over-the-counter minoxidil for androgenetic alopecia, private-prescription finasteride for men, and NICE-approved JAK inhibitors baricitinib and ritlecitinib for severe alopecia areata.
The appropriate treatment for hair loss depends entirely on the underlying cause, which is why accurate diagnosis is so important. Treatment options in the UK are guided by NICE Clinical Knowledge Summaries (CKS), relevant NICE Technology Appraisals, and guidance from the British Association of Dermatologists (BAD) and the Primary Care Dermatology Society (PCDS).
For androgenetic alopecia, the most widely used treatments include:
-
Minoxidil — available over the counter (without a prescription) as a topical solution or foam in 2% and 5% strengths. It is applied directly to the scalp and works by prolonging the anagen phase of the hair cycle. It is suitable for both men and women, though consistent long-term use is required and hair loss is likely to return if treatment is stopped. Minoxidil for androgenetic alopecia is not routinely available on the NHS and is typically purchased privately.
-
Finasteride 1 mg — an oral medication for men that works by inhibiting the conversion of testosterone to DHT. For male pattern hair loss, finasteride is generally prescribed via private prescription in the UK and is not routinely funded by the NHS. It is contraindicated in women who are pregnant or may become pregnant due to the risk of harm to a male foetus; women who are or may become pregnant should not handle crushed or broken tablets. Finasteride is associated with sexual side effects and, in some men, mood changes; shared decision-making and review of the SmPC are advised before starting treatment.
For telogen effluvium, treatment focuses on identifying and addressing the underlying trigger — whether correcting a nutritional deficiency, managing stress, or adjusting medications. In many cases, hair regrowth occurs naturally once the cause is resolved.
For alopecia areata, treatment options may include topical or intralesional corticosteroids, contact immunotherapy, or referral to specialist dermatology services. NICE has approved two JAK inhibitors for severe alopecia areata in adults (and ritlecitinib also in adolescents aged 12 and over) via Technology Appraisals:
-
Baricitinib (NICE TA878) — for severe alopecia areata in adults
-
Ritlecitinib (NICE TA973) — for severe alopecia areata in adults and adolescents aged 12 and over
Both are specialist-initiated treatments with defined eligibility criteria and monitoring requirements under their respective NICE Technology Appraisals.
For tinea capitis, oral antifungal treatment (typically terbinafine or griseofulvin, depending on the causative organism) is required; topical antifungals alone are insufficient.
Non-pharmacological support is also available. The NHS may provide wigs or hair prostheses for eligible patients with certain conditions (such as alopecia areata) — your GP or specialist can advise on local availability. Camouflage products and scalp micropigmentation are options some people explore independently.
The NHS recognises the psychological impact of hair loss, and referral to counselling or psychological support services may be appropriate. Alopecia UK (alopecia.org.uk) provides peer support, practical guidance, and signposting to further resources.
If cannabis use is identified as a potential contributing factor, a GP may discuss harm reduction strategies or refer to appropriate support services, in line with NHS guidance on substance use.
Frequently Asked Questions
Is there clinical proof that smoking cannabis causes hair loss?
No. There is currently no definitive clinical evidence from large-scale, peer-reviewed studies establishing that smoking or consuming cannabis directly causes hair loss in otherwise healthy individuals.
Could cannabis affect hair growth through hormones or the endocannabinoid system?
Theoretical mechanisms have been proposed, including CB1 receptor activation in hair follicles and possible effects on sex hormone levels, but none of these pathways has been confirmed as clinically significant in humans.
What should I do if I use cannabis and am experiencing hair loss?
Speak openly with your GP, who can assess the full clinical picture, arrange appropriate blood tests, and consider all potential causes — including nutritional deficiencies, thyroid disorders, and androgenetic alopecia — before attributing hair loss to cannabis use.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
